Highlighted videos
Data-Driven Drug Discovery
QIAGEN and NVIDIA collaboration to advance AI driven drug discovery
NVIDIA and QIAGEN are collaborating to bring trustworthy, contextual AI to drug discovery. By...
HGMD
Hybrid Variant Interpretation: Combining AI + Expert Curation to Streamline...
As hereditary NGS testing grows more complex, clinical labs must interpret variants with greater speed...
QIAGEN IPA
QIAGEN IPA
Generate, explore, and test hypotheses using the Biomedical Knowledgebase in IPA
Did you know that IPA can build networks from scratch? Using the QIAGEN...
QIAGEN IPA
Metabolomics data upload and analysis using QIAGEN Ingenuity Pathway Analysis
Per user request, we are hosting a training specifically focused on...
QIAGEN IPA
Decoding neuropathies with TDP-43 and CRISPR
Neurodegenerative disorders linked to protein dysfunction are difficult to...
QIAGEN IPA
QIAGEN Ingenuity Pathway Analysis (IPA) for grant writing and publications
IPA is more than just an analysis program; it can also help you write grants...
QIAGEN CLC Genomics
QIAGEN CLC Genomics
Discovering Novel Plant Genome Transcripts with Hybrid Long- and Short-Read RNA-seq Data
This webinar walks participants through a complete de novo transcript...
QIAGEN CLC Genomics
Reliable viral detection by NGS for GMP environments
Good manufacturing practices (GMP) environments, such as biologics production...
QIAGEN CLC Genomics
Influenza Strain Typing Made Easy with QIAGEN CLC Genomics Workbench
Influenza is a highly contagious disease that affects humans and multiple...
QIAGEN CLC Genomics
Simplify bulk and single-cell ATAC-seq analysis with QIAGEN CLC Genomics Workbench
ATAC-seq is a powerful technique for assessing chromatin accessibility and...
QIAGEN OmicSoft and Biomedical Knowledge Base
QIAGEN OmicSoft and Biomedical Knowledge Base
OmicSoft Explorer Hands-on Workshop: Easily search and interpret deeply curated 'omics datasets
This hands-on workshop will cover a highly requested use case using OmicSoft...
QIAGEN OmicSoft and Biomedical Knowledge Base
Target discovery in Alzheimer’s: Linking causal biology with CNS expression
Public neuroscience datasets are abundant, but they prove difficult to...
QIAGEN OmicSoft and Biomedical Knowledge Base
Reduce Discovery Risk Using Comorbidity Data, Omics and Knowledge Graphs
Comorbidity data can reveal unexpected and insightful connections between...
QIAGEN OmicSoft and Biomedical Knowledge Base
Identify drug target receptors and investigate their mechanism of action
Biomedical KB-HD analysis in Neo4j enables researchers to explore complex...
日本語 (Japanese)
日本語 (Japanese)
01. QIAGEN OmicSoft チュートリアル1 概要
OmicSoft の概要と製品の種類についての説明です。
日本語 (Japanese)
02. QIAGEN OmicSoftチュートリアル2 起動と Land の選択
起動後、まず最初に利用するLand を選択します。
日本語 (Japanese)
03. QIAGEN OmicSoftチュートリアル3 グループ分け (Y軸の分類）
表示されているグラフのY軸は疾患の種類、喫煙歴等様々なメタデータで分類できます。
日本語 (Japanese)
04. QIAGEN OmicSoftチュートリアル4 遺伝子の検索、サンプルの絞り込み
単一遺伝子の検索、および様々なメタデータでサンプルの絞り込みを行う方法を解説します。
QCI Interpret for Oncology
QCI Interpret for Oncology
Exclusive first look at the new QCI Interpret Summer 2026 release: Prepare your lab
Join us for an exclusive preview of the Summer 2026 release of QCI Interpret,...
QCI Interpret for Oncology
Is it oncogenic? Comparing guidelines and QCI Interpret CDS for cancer variant interpretation
Accurate clinical interpretation of somatic cancer variants is critical for...
QCI Interpret for Oncology
S2I oncology
S2I oncology
QCI Interpret for Oncology
Streamline clinical reporting for high-throughput oncology NGS testing with QCI Interpret One
With the rising demand for personalized cancer treatments, clinical...
Gene Variant Databases
Gene Variant Databases
HGMD Pro in action: Search, curate and classify genetic variants - Session 1
As the use of next-generation sequencing (NGS) in diagnostics increases, so...
Gene Variant Databases
Germline and Somatic Variant Investigation using COSMIC, HGMD and QCI-IT
The accurate identification and annotation of germline and somatic variants...
Gene Variant Databases
Advances in Genomic Testing for Rare Disease Diagnostics
Over the past decade, whole-exome and whole-genome sequencing have...
Gene Variant Databases
Leveraging expert-curated knowledge from COSMIC and QIAGEN to avoid pitfalls, qualify candidate drug targets, and accelerate early discovery
The cancer drug discovery landscape is shifting. While research continues to...
QCI Interpret for Hereditary
QCI Interpret for Hereditary
Exclusive first look at the new QCI Interpret Summer 2026 release: Prepare your lab
Join us for an exclusive preview of the Summer 2026 release of QCI Interpret,...
QCI Interpret for Hereditary
Screening 100,000 newborns using whole genome sequencing: The Genomics England Generation Study
In this on-demand recording from ACMG 2024, hear from Dr. David Bick,...
QCI Interpret for Hereditary
QCI Interpret for Hereditary Disorders
Clinical labs face significant challenges in interpreting germline variants...
QCI Secondary Analysis
QCI Secondary Analysis
How decentralized and small labs can adopt high-throughput NGS analysis with limited time and resource investment
Next-generation sequencing (NGS) has rapidly gained popularity as a...
QCI Secondary Analysis
Introducing QCI Secondary Analysis
Introducing QCI Secondary Analysis, a new cloud-based service for NGS...
Cancer Drug Discovery
Cancer Drug Discovery
Single-cell RNA-seq, cell hashing and spatial transcriptomics
In this training, you will learn how to analyze and interpret your own single...
Cancer Drug Discovery
Targeting MUC16 Neoantigens in Pancreatic Cancer: Precision Oncology and Indication Selection
This webinar shows how we enable identification and prioritization of a novel...
Cancer Drug Discovery
Data curation as a key element in successful data science strategy
Learn the 7 habits of effective manual curation that QIAGEN Digital Insights...
Cancer Drug Discovery
Exploring drug response in low-grade glioma
This webinar introduces the Tumor Microenvironment (TME) Pathway in QIAGEN’s...
Data-Driven Drug Discovery
Data-Driven Drug Discovery
How Single-Cell Atlases and AI Are Reshaping Drug Discovery
Large-scale single-cell datasets are creating new opportunities to understand...
Data-Driven Drug Discovery
AI meets expertise: A hybrid workflow for modern target ID
AI excels at identifying patterns and generating insights across large...
Data-Driven Drug Discovery
Beyond enrichment Causal discovery powered by Neo4j & QIAGEN Discovery KB+
One click from your target gene to disease drivers, drug candidates and...
Data-Driven Drug Discovery
QIAGEN and NVIDIA collaboration to advance AI driven drug discovery
NVIDIA and QIAGEN are collaborating to bring trustworthy, contextual AI to...
Franklin
Franklin
Franklin by QIAGEN for Hereditary Cancer Variant Interpretation
Accurate variant interpretation is critical in hereditary cancer genetics,...
Franklin
Get Hands-on with Franklin + HGMD – May 28 (Spanish)
Welcome to one of our exclusive, hands-on virtual workshops to explore...
Franklin
Get Hands-on with Franklin + HGMD – May 27 (Portuguese)
Welcome to one of our exclusive, hands-on virtual workshops to explore...
Franklin
Accelerating hereditary variant interpretation: HGMD in Franklin
“Reliable AI”? Sounds like a contradiction, but with HGMD in Franklin, it’s...
Genomics for Health
Genomics for Health
Disrupting Healthcare Using Deep Data, Remote Monitoring and AI
Today’s healthcare system largely reacts to illness rather than preventing...
Genomics for Health
Shared Pathways, Many Origins: How Diverse Genetic Risk Targets Share Developmental Networks in Autism Spectrum Disorder
Over two decades of research have uncovered over 100 genes with rare...
Neuroscience
Neuroscience
Decoding neuropathies with TDP-43 and CRISPR
Neurodegenerative disorders linked to protein dysfunction are difficult to...
Neuroscience
Expanding rare disease horizons Developing a diagnostic algorithm for episodic ataxias
In the absence of genetic testing, is there a clear way forward with...
Neuroscience
Target discovery in Alzheimer’s: Linking causal biology with CNS expression
Public neuroscience datasets are abundant, but they prove difficult to...
Neuroscience
Shared Pathways, Many Origins: How Diverse Genetic Risk Targets Share Developmental Networks in Autism Spectrum Disorder
Over two decades of research have uncovered over 100 genes with rare...